PSMA is a transmembrane glycoprotein with high expression in most prostate cancer cells although can be expressed in endothelial cells in non-prostate cancer tumours (NPCaT), particularly in the context of neovascularization [5]. Here, FOLH1 is linked to prostate carcinoma.